Bristol “Dear Doctor” Letter: Abilify Shows No “Signal” For Diabetes

An “exhaustive review” of the aripiprazole database revealed “no increased signal for diabetes,” Bristol says in health care professionals letter explaining the new class warning for atypical antipsychotics.